Viewing Study NCT00006100


Ignite Creation Date: 2025-12-26 @ 12:18 PM
Ignite Modification Date: 2026-01-23 @ 2:45 PM
Study NCT ID: NCT00006100
Status: UNKNOWN
Last Update Posted: 2013-12-18
First Post: 2000-08-03
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Allogeneic Epstein Barr Virus-Specific Cytotoxic T-Lymphocytes in Treating Patients With Progressive, Relapsed, or Refractory Hodgkin's Lymphoma
Sponsor: Milton S. Hershey Medical Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None recurrent adult Hodgkin lymphoma View